About Syner-G
Syner-G is a Healthcare company based in Southborough (United States) founded in 2007. Provider of regulatory affair and quality management services. Syner-G has completed 2 acquisitions, including Impact Pharmaceutical Services and RMC Pharma. Its website synergbiopharma.com draws about 10 thousand monthly visits. Syner-G offers products and services including Pharmaceutical Development, Regulatory Strategy, Medical Writing, Functional Outsourcing, and Quality and Compliance. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its competitors include Indegene, IntegriChain and ClearView Healthcare Partners; 2 of its 3 listed competitors have raised funding.
Company details
Syner-G offers Pharmaceutical Development, Regulatory Strategy, Medical Writing, Functional Outsourcing, Quality and Compliance while focusing on providing healthcare solutions, biopharma outsourcing, offering consulting services, and diversified. Provider of regulatory affair and quality management services. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
- Headquarters Southborough, United States
- SectorsHealthcare
- Website synergbiopharma.com
- Social LinkedIn
- Investors
- Investments & AcquisitionsImpact Pharmaceutical Services
& 1 more
Products & Services of Syner-G
Syner-G offers a comprehensive portfolio of products and services, including Pharmaceutical Development, Regulatory Strategy, Medical Writing, Functional Outsourcing, and Quality and Compliance.
Provides chemistry, manufacturing, and controls for drug development.
Offers end-to-end strategy for regulatory submissions and compliance.
Delivers accurate regulatory and clinical documents for biopharma.
Supports global programs with dedicated regulatory teams.
Ensures quality systems and audits for pharmaceutical operations.
Funding Insights of Syner-G
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Syner-G with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in Syner-G
Syner-G has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Riverside Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are made in technology and healthcare sectors. | riversidepartners.com | Boston, United States |
Investor details for Syner-G
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Syner-G
50 people are tracked at Syner-G (23 in leadership, 27 in team).
| Name | Role | Group |
|---|---|---|
Scott Bergeron | Chief Commercial Officer (cco) | Leadership |
Davida Blackman | Vice President, CMC Development and Project Management, Biologics | Leadership |
Myke Scoggins | Senior Director, CMC Development and Project Management | Leadership |
Ron Kraus | Chief Executive Officer | Leadership |
Neil Butera | Chief Commercial Officer (CCO) | Leadership |
Ed Ciolkowski | Vice President - CMC Development & Head of Analytical Development | Leadership |
Karen Casey | Chief People Officer | Leadership |
Traci Beevers | Sr. Director, Human Resources | Leadership |
Kevin Swiss | Vice President | Leadership |
Frank Sorce | Sr. Director, BD & ELT Member | Leadership |
Stephen F. Coté | Chief Financial Officer | Leadership |
Melissa Dunne | Senior Director, Finance & Accounting | Leadership |
Tom Puthiaparampil Ph. D | Country Head - India | Leadership |
Nancy Gasper Smith | Senior Vice President, Medical Writing Services | Leadership |
Mao Yin | Senior Director of CMC Development and Project Management | Leadership |
Alison O'Kane | Director Of Accounting | Leadership |
Christina Williams | Senior Director, Medical Writing Services | Leadership |
Libby Russell | Vice President | Leadership |
Ingrid M. Levitt | Senior Consultant (director) RA CMC | Leadership |
Morgan Marin Watson | Director, Product Lifecycle Management | Leadership |
30 more people are available in the full profile.
Complete people profiles for Syner-G
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Syner-G
Syner-G has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Impact Pharmaceutical Services and RMC Pharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
CMC services are offered for pharmaceutical and biotech development. | rmcpharma.com | Longmont, United States | 2004 | Jan 2023 | •••• | |
CRO offering clinical development services | impactpharma.com | Durham, United States | 2009 | Feb 2022 | •••• |
Complete acquisition details for Syner-G
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Syner-G
4 dated milestones of Syner-G across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Syner-G is founded.
- Funding First funding round.
- Acquisition Acquires Impact Pharmaceutical Services.
- Acquisition Acquires RMC Pharma.
Competitors of Syner-G
Syner-G has 3 listed competitors in our database, 2 of them funded. They include Indegene, IntegriChain and ClearView Healthcare Partners.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| indegene.com | 1998 | Princeton, United States | $220M | 350 | Suite solutions are provided for payers and healthcare providers. | |
| integrichain.com | 2005 | Philadelphia, United States | $2M | 320 | Inventory, order and customer relationship management solution for life science suppliers. | |
| clearviewhcp.com | 2008 | Newton, United States | 381 | Strategic consulting services are provided to life sciences companies. |
Detailed competitors of Syner-G
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Syner-G
The website of Syner-G (synergbiopharma.com) receives about 10.4K visits a month.
- Monthly visits10.4K
▲ 10.1% vs previous month
Websites whose visitors overlap most with Syner-G. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
chiesiusa.com | chiesiusa.com | 100% | #1,397,563 | – | |
| medpharm.com | 91% | 5.3K | #6,145,162 | View details | |
| skan.com | 89% | 28.1K | #1,143,966 | View details | |
newdrugapprovals.org | newdrugapprovals.org | 88% | #1,546,215 | – | |
| sproutpharmaceuticals.com | 88% | 1.3K | #12,729,442 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for Syner-G
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Syner-G (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Syner-G
Complete news archive for Syner-G
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syner-G
Syner-G was founded in 2007 and raised its 1st funding round 13 years after it was founded.
Syner-G is headquartered in Southborough, United States. It is registered at Southborough, Massachusetts, United States.
Syner-G offers Pharmaceutical Development, Regulatory Strategy, Medical Writing, Functional Outsourcing, Quality and Compliance while focusing on providing healthcare solutions, biopharma outsourcing, offering consulting services, and diversified. Provider of regulatory affair and quality management services. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.
Syner-G's top competitors include Indegene, IntegriChain and ClearView Healthcare Partners.
Syner-G offers Pharmaceutical Development, Regulatory Strategy, Medical Writing, Functional Outsourcing, and Quality and Compliance.
Syner-G has made 2 acquisitions, including Impact Pharmaceutical Services, and RMC Pharma.
Syner-G has 1 investor. Key investors include Riverside Partners.